Fish Oil Is Good Medicine for Heart Failure

THURSDAY, Nov. 14, 2019 -- Fish oil might help people with heart failure avoid repeat trips to the hospital, a new study suggests. The findings come from an analysis of a clinical trial first published last year, where researchers tested the effects...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news

Related Links:

Publication date: Available online 24 September 2019Source: Canadian Journal of DiabetesAuthor(s): Vincent C. WooAbstractAdults with type 2 diabetes mellitus can benefit from pharmacotherapies that lower their risk for cardiovascular disease. This review describes the salient findings from sodium-glucose cotransporter-2 (SGLT2) inhibitor cardiovascular outcome trials that serendipitously revealed the cardiorenal benefits of SGLT2 inhibitors in adults with type 2 diabetes mellitus who either have established cardiovascular disease or multiple cardiovascular risk factors. It also summarizes the findings from other phase 3 cl...
Source: Canadian Journal of Diabetes - Category: Endocrinology Source Type: research
Authors: Lavallee DC, Blakeney EA, Yu Y, Johnson R, Liner DA, Murphy NL, Pambianco SB, Paquet R, Spacciante L, Woodard NY, Zierler BK Abstract For patients with advanced heart failure involvement as a member of the healthcare team is critical to safe, high-quality and goal-directed care. While recognized as an important aspect of care, patient engagement is not yet a standard practice. This presents an opportunity for professional education and development in team-based care. This short report describes the development of a Community and Patient Advisory Team (CPAT) formed to support patient involvement in int...
Source: Journal of Interprofessional Care - Category: Health Management Tags: J Interprof Care Source Type: research
Publication date: Available online 13 December 2019Source: Canadian Journal of CardiologyAuthor(s): Giuseppe Santoro, Gemma Salerno, Maurizio Cappelli Bigazzi, Paolo GolinoSummaryA 61 years-old patient with post-ischemic severe congestive heart failure (NYHA class III-IV) due to left ventricular pseudo-aneurysm and functional mitral valve regurgitation refractory to medical therapy was successfully treated by trans-catheter occlusion of the aneurismal sac with an Amplatzer Septal Occluder device and implantation of multiple MitraClips. After the procedure, his clinical conditions dramatically improved to NYHA class I.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Publication date: Available online 12 December 2019Source: Canadian Journal of CardiologyAuthor(s): Christopher C. Cheung, Thomas M. Roston, Jason G. Andrade, Matthew T. Bennett, Margot K. DavisAbstractCardiac amyloidosis occurs secondary to the deposition of insoluble protein fibrils in cardiac tissue leading to progressive myocardial dysfunction, clinical heart failure, and arrhythmia. In recent years, increasing awareness and improved screening have resulted in an increased prevalence of cardiac amyloidosis, with contemporary estimates reporting a prevalence of 18 to 55 cases per 100,000 person-years, and accounting for...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
ConclusionsRegression of conduction abnormalities was frequent among patients undergoing coronary angiography, primarily for suspected acute coronary syndrome. After adjustment for important confounders including extent of coronary artery disease, infranodal conduction abnormalities were associated with a modest increase in cardiovascular risk.
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Publication date: Available online 12 December 2019Source: American Heart JournalAuthor(s): Mark Loeb, Hisham Dokainish, Antonio Dans, Lia M Palileo-Villanueva, Ambuj Roy, Kamilu Karaye, Jun Zhu, Yan Liang, Fastone Goma, Albertino Damasceno, Khalid F AlHabib, Gerald Yonga, Charles Mondo, Wael Almahmeed, Arif Al Mulla, Salim Yusuf, IVVE investigators
Source: American Heart Journal - Category: Cardiology Source Type: research
DiscussionThe EMMY trial will test empagliflozin in patients with AMI regardless of their diabetic status. The EMMY trial may therefore underpin the concept of SGLT2 inhibition to improve cardiac remodeling, pre-and afterload reduction and cardiac metabolism regardless of its antidiabetic effects. Results will provide the rationale for the conduct of a cardiovascular outcome trial to test the effect of empagliflozin in patients with AMI.
Source: American Heart Journal - Category: Cardiology Source Type: research
Publication date: Available online 13 December 2019Source: Medicina Intensiva (English Edition)Author(s): F.J. Martín-Sánchez, G. Llopis García, M. González-Colaço Harmand, C. Fernandez Pérez, J. González del Castillo, P. Llorens, P. Herrero, J. Jacob, V. Gil, A. Domínguez-Rodriguez, X. Rossello, O. Miró, on behalf of the OAK Registry researchers, Researchers from the OAK registry, Esther Rodríguez Adrada, María Carmen Santos, Lucía Salgado, Berenice Nayla Brizzi, María Luisa Docavo, María Suárez Cadenas, Carolina Xipel...
Source: Medicina Intensiva - Category: Intensive Care Source Type: research
Conclusions Preoperative vitamin D was not associated with a composite of postoperative 30-day cardiac outcomes. However, there was a significant association between vitamin D deficiency and a composite of infectious complications and decreased kidney function. While renal effects were not clinically meaningful, the effect of vitamin D supplementation on infectious complications requires further study.
Source: Anesthesiology - Category: Anesthesiology Source Type: research
Contributors : Kenneth B Margulies ; Thomas P CappolaSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe Myocardial Applied Genomics Network (MAGNet; www.med.upenn.edu/magnet), collects and banks human cardiac tissue for genomic research. All subjects or next of kin provided written informed consent for tissue donation and analyses and all study protocols were approved by relevant institutional review boards. Left ventricular free-wall tissue was harvested at the time of cardiac surgery from subjects with heart failure undergoing transplantation and from unused donor hearts with appar...
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Expression profiling by high throughput sequencing Homo sapiens Source Type: research
More News: Cardiology | Clinical Trials | Fish | Fish Oil | General Medicine | Heart | Heart Failure | Hospitals | Study